Yoshihiro Wada
Biological Research Laboratories
Sankyo Co.
Ltd. 1-2-58
Hiromachi
Japan
Name/email consistency: high
- Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes. Wada, Y., Shimada, K., Sugimoto, K., Kimura, T., Ushiyama, S. Int. Immunopharmacol. (2006)
- R-130823, a novel inhibitor of p38 MAPK, ameliorates hyperalgesia and swelling in arthritis models. Wada, Y., Nakajima-Yamada, T., Yamada, K., Tsuchida, J., Yasumoto, T., Shimozato, T., Aoki, K., Kimura, T., Ushiyama, S. Eur. J. Pharmacol. (2005)
- Novel p38 MAP kinase inhibitor R-130823 suppresses IL-6, IL-8 and MMP-13 production in spheroid culture of human synovial sarcoma cell line SW 982. Wada, Y., Shimada, K., Kimura, T., Ushiyama, S. Immunol. Lett. (2005)









